19 December 2013 - Deborah Wilkes
Archived
Meda is set to acquire ZpearPoint – including global rights to its EB24 OTC product for treating dental erosion – in a deal worth up to SEK77.0 million (US$11.8 million).
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.